Glycomine Announces Encouraging Efficacy Data from Ongoing Phase 2 Clinical Study in PMM2-CDGJune 19, 2024Read article
Aura Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business HighlightsJune 19, 2024Read article
CuraSen Therapeutics Announces Oral Presentation of Additional Positive Phase 2a Data with CST-2032/CST-107 in Patients with Alzheimer’s or Parkinson’s Disease at AD/PD™ 2024 International ConferenceJune 19, 2024Read article
Aura Biosciences Reports First Quarter 2024 Financial Results and Business HighlightsJune 19, 2024Read article
Aura Biosciences to Host Virtual KOL Event “Pioneering a New Standard of Care In Ocular Oncology” on May 29, 2024June 19, 2024Read article
Aura Biosciences to Participate in the Jefferies Global Healthcare ConferenceJune 19, 2024Read article
Rare Disease Day 2024 – Call for greater awareness of X-linked adrenoleukodystrophy and cerebral adrenoleukodystrophy – special film launchedMarch 4, 2024Read article
Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)February 5, 2024Read article
